Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07029464

Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis

This is a retrospective, multicenter cohort study to compare short- and long-term outcomes between robotic and laparoscopic hemicolectomy of right colon cancer.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Robotic Surgical Procedures Cancer Laparoscopic Abdominal Surgery Neoplasms Right Colon Tumors

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1.Underwent radical right hemicolectomy by Da Vinci robotic or laparoscopic surgery 2.Postoperative pathology confirmed right colon adenocarcinoma (pT2-T4aNxM0; including cecal adenocarcinoma, ascending colon adenocarcinoma, hepatic flexure colon adenocarcinoma, and proximal transverse colon adenocarcinoma) 3.Complete clinical data and pathological results available

Exclusion criteria

  • 1.Received neoadjuvant therapy prior to surgery 2.History of other malignancies in the past 5 years (except cured cervical carcinoma in situ, basal cell carcinoma, or squamous cell carcinoma of the skin) 3.Distant metastases (e.g., liver, lung) or extensive abdominal/pelvic metastases confirmed by contrast-enhanced CT, PET-CT, or intraoperative exploration 4.Comorbid neurological/psychiatric disorders impairing ability to express informed consent 5.Poor systemic condition with contraindications to general anesthesia 6.Severe obesity (BMI >35 kg/m²) 7.Severe widespread abdominal adhesions precluding safe pneumoperitoneum establishment 8.Emergency surgery due to tumor perforation or obstruction 9.Refusal to provide informed consent

Treatment and study plan

Primary outcomes

  1. 3-year overall survival (OS) rate and 3-year disease-free survival (DFS) rate

    Time frame: （OS）From post-operation until death or the 3-year study endpoint （DFS）From post-operation to tumor recurrence or the 3-year study endpoint

Secondary outcomes

  1. Operative time

    Time frame: Periprocedural

  2. Intraoperative blood loss

    Time frame: Periprocedural

  3. Time to first flatus/bowel movement

    Time frame: Periprocedural

  4. Time to liquid diet initiation

    Time frame: Periprocedural

  5. Time to ambulation

    Time frame: Periprocedural

  6. Postoperative hospital stay duration

    Time frame: Up to 30 days

  7. Postoperative complications

    Time frame: From end of surgery to 30 days postoperatively

    Surgery-related adverse events within 30 days, graded via the Clavien-Dindo classification system

  8. Postoperative white blood cell (WBC) count

    Time frame: On postoperative days 1, 3, and 5

    Measured on postoperative days 1, 3, and 5

  9. Postoperative C-reactive protein (CRP) level

    Time frame: On postoperative days 1, 3, and 5

    Measured on postoperative days 1, 3, and 5

  10. Pain score

    Time frame: On postoperative days 1, 3, and 5

    Assessed using the Visual Analog Scale (VAS) on postoperative days 1, 3, and 5

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Nanchang University

Other

Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences
  • Fudan University
  • Ganzhou City People's Hospital
  • Huadong Hospital
  • Jiangxi Provincial People's Hopital
  • Nanfang Hospital, Southern Medical University
  • Pingxiang People 's Hospital
  • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Second Xiangya Hospital of Central South University
  • Shandong University Second Hospital
  • The Affiliated Hospital of Qingdao University
  • The First Affiliated Hospital of Zhengzhou University
  • The Second Affiliated Hospital of Harbin Medical University
  • Three Gorges Hospital of Chongqing University
  • Tianjin Third Central Hospital

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jun 19, 2025
Registry last updated
Jun 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.